HYPAQUE-M,90%
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Nov 1955
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYPAQUE-M 90% is an injectable contrast medium approved in 1955 by GE HealthCare, used as a diagnostic radiographic agent. The product is a meglumine diatrizoate formulation administered via injection for imaging procedures. It functions as an iodinated contrast agent to enhance visualization in radiological examinations.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential downsizing of dedicated commercial teams and shift toward generic or successor-product focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and LOE approaching, career opportunities on HYPAQUE-M 90% are minimal and focused on wind-down, transition planning, and generic management rather than growth. Professionals assigned to this asset should expect minimal headcount growth and should strategically position themselves for transition to GE HealthCare's newer imaging products or competing companies.
Brand Manager
Worked on HYPAQUE-M,90% at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.